Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic CancerRoberto Alva‐Ruiz, Mark J. Truty, Lindsey A. Gregory et al.|Annals of Surgical Oncology|2021Cited by 68
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic AdenocarcinomaAmro M. Abdelrahman, Mark J. Truty, Ajit H. Goenka et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 59